Linc Group

Linc is a prominent Swedish investment company focused on the Nordic life science industry, primarily targeting pharmaceutical, biotechnology, and medical technology sectors. Founded by Bengt Julander, the firm specializes in early-stage investments in drug development and more mature-stage investments in medical technology. Linc operates as an active owner, providing capital and strategic expertise to help its portfolio companies achieve commercial success and clinical milestones. The company is publicly traded on Nasdaq Stockholm and maintains a diverse portfolio of both listed and unlisted holdings, including notable names such as Calliditas Therapeutics and Medivir.